Table 3 Diagnosis and treatment characteristics and distribution by LTFU status of adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009–2016 (n = 305)
Diagnosis and Treatment characteristics | LTFU (n1 = 45) Frequency (%) | No-LTFU (n2 = 260) Frequency (%) | Total (n = 305) Frequency (%) | LTFU Rate [95%CI] Per 100 PYs | P-value |
|---|---|---|---|---|---|
Adverse drug events | 0.0087 | ||||
No | 39 (86.7) | 156 (60.0) | 192 (63.0) | 6.0 [4.4, 8.4] | |
Yes | 6 (13.3) | 104 (40.0) | 113 (37.0) | 3.3 [1.2, 4.3] | |
History OI/s | 0.0180 | ||||
No | 3 (6.7) | 59 (22.7) | 62 (20.3) | 1.4 [0.5, 4.5] | |
Yes | 42 (93.3) | 201 (77.3) | 243 (79.7) | 5.3 [3.9, 7.2] | |
TB Category | 0.0530 | ||||
PTB | 16 (35.6) | 116 (44.6) | 132 (43.3) | 3.1 [1.9, 5.1] | |
EPTB/Mixed | 29 (64.4) | 144 (55.4) | 173 (56.7) | 6.0 [4.2, 8.7] | |
TB treatment completion | < 0.001 | ||||
No | 13 (28.9) | 39 (15.0) | 52 (17.0) | 35.7 [20.7, 61.5] | |
Yes | 32 (71.1) | 221 (85.0) | 253 (83.0) | 3.3 [2.4, 4.7] | |
IPT | 0.0025 | ||||
on | 1 (2.2) | 47 (18.1) | 48 (15.7) | 5.6 [4.2, 7.6] | |
off | 44 (97.8) | 213 (81.9) | 257 (84.3) | 0.5 [0.1, 3.3] | |
CPT | 0.9189 | ||||
Off | 7 (15.6) | 44 (16.9) | 51 (16.7) | 4.7 [2.2, 9.8] | |
On | 38 (84.4) | 216 (83.1) | 254 (83.3) | 4.5 [3.3, 6.2] | |